0.00Open0.10Pre Close0 Volume34 Open Interest88.00Strike Price0.00Turnover2975.14%IV9.20%PremiumDec 6, 2024Expiry Date0.00Intrinsic Value100Multiplier-4DDays to Expiry0.10Extrinsic Value100Contract SizeAmericanOptions Type0.0451Delta0.0172Gamma806.75Leverage Ratio-119.5187Theta0.0000Rho36.41Eff Leverage0.0002Vega
DexCom Stock Discussion
Revenue came in at $994.2 million, topping the forecast of $990.71 million and showing growth from last year's $975 million.
The company announced that Teri Lawver, EVP and Chief Commercial Officer, will retire by year-end, with CEO Kevin Sayer temporarily leading the commercial team.
DexCom reaffirmed its 2024 sales outl...
No comment yet